Although not specific, CEA can have a role as a marker of tumor progression and invasion, especially in MTC with low or no production of CT, as its blood levels are associated with tumor size, lymph node involvement and also distant metastases [93,94]. The gene discussed is CEACAM5; the disease is neoplasm.